TY - JOUR
T1 - Non-dispensing pharmacist integrated in the primary care team
T2 - effect on the quality of physician’s prescribing, a non-randomised comparative study
AU - Sloeserwij, Vivianne M.
AU - Zwart, Dorien L.M.
AU - Hazen, Ankie C.M.
AU - Poldervaart, Judith M.
AU - Leendertse, Anne J.
AU - de Bont, Antoinette A.
AU - Bouvy, Marcel L.
AU - de Wit, Niek J.
AU - de Gier, Han J.
N1 - Funding Information:
A research grant was obtained from the Netherlands Organisation for Health Research and Development (Grant Agreement Number 80-833600-98-10206). Implementation of NDPs was financed by an unconditional grant of the Foundation Achmea Healthcare, a Dutch health insurance company (Project Number Z456). Both study sponsors had no role in the design of the study, nor in the data collection, analyses, interpretation of the data and in the writing of the report or in the decision to submit the manuscript for publication. Acknowledgements
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Background Especially in elderly with polypharmacy, medication can do harm. Clinical pharmacists integrated in primary care teams might improve quality of pharmaceutical care. Objective To assess the effect of non-dispensing clinical pharmacists integrated in primary care teams on general practitioners’ prescribing quality. Setting This study was conducted in 25 primary care practices in the Netherlands. Methods Non-randomised, controlled, multi-centre, complex intervention study with pre-post comparison. First, we identified potential prescribing quality indicators from the literature and assessed their feasibility, validity, acceptability, reliability and sensitivity to change. Also, an expert panel assessed the indicators’ health impact. Next, using the final set of indicators, we measured the quality of prescribing in practices where non-dispensing pharmacists were integrated in the team (intervention group) compared to usual care (two control groups). Data were extracted anonymously from the healthcare records. Comparisons were made using mixed models correcting for potential confounders. Main outcome measure Quality of prescribing, measured with prescribing quality indicators. Results Of 388 eligible indicators reported in the literature we selected 8. In addition, two more indicators relevant for Dutch general practice were formulated by an expert panel. Scores on all 10 indicators improved in the intervention group after introduction of the non-dispensing pharmacist. However, when compared to control groups, prescribing quality improved solely on the indicator measuring monitoring of the renal function in patients using antihypertensive medication: relative risk of a monitored renal function in the intervention group compared to usual care: 1.03 (95% CI 1.01–1.05, p-value 0.010) and compared to usual care plus: 1.04 (1.01–1.06, p-value 0.004). Conclusion This study did not demonstrate a consistent effect of the introduction of non-dispensing clinical pharmacists in the primary care team on the quality of physician’s prescribing. This study is part of the POINT-study, which was registered at The Netherlands National Trial Register with trial registration number NTR‐4389.
AB - Background Especially in elderly with polypharmacy, medication can do harm. Clinical pharmacists integrated in primary care teams might improve quality of pharmaceutical care. Objective To assess the effect of non-dispensing clinical pharmacists integrated in primary care teams on general practitioners’ prescribing quality. Setting This study was conducted in 25 primary care practices in the Netherlands. Methods Non-randomised, controlled, multi-centre, complex intervention study with pre-post comparison. First, we identified potential prescribing quality indicators from the literature and assessed their feasibility, validity, acceptability, reliability and sensitivity to change. Also, an expert panel assessed the indicators’ health impact. Next, using the final set of indicators, we measured the quality of prescribing in practices where non-dispensing pharmacists were integrated in the team (intervention group) compared to usual care (two control groups). Data were extracted anonymously from the healthcare records. Comparisons were made using mixed models correcting for potential confounders. Main outcome measure Quality of prescribing, measured with prescribing quality indicators. Results Of 388 eligible indicators reported in the literature we selected 8. In addition, two more indicators relevant for Dutch general practice were formulated by an expert panel. Scores on all 10 indicators improved in the intervention group after introduction of the non-dispensing pharmacist. However, when compared to control groups, prescribing quality improved solely on the indicator measuring monitoring of the renal function in patients using antihypertensive medication: relative risk of a monitored renal function in the intervention group compared to usual care: 1.03 (95% CI 1.01–1.05, p-value 0.010) and compared to usual care plus: 1.04 (1.01–1.06, p-value 0.004). Conclusion This study did not demonstrate a consistent effect of the introduction of non-dispensing clinical pharmacists in the primary care team on the quality of physician’s prescribing. This study is part of the POINT-study, which was registered at The Netherlands National Trial Register with trial registration number NTR‐4389.
KW - Non-dispensing pharmacist
KW - Pharmaceutical care
KW - Prescribing
KW - Process indicator
KW - Quality
KW - Reproducibility of Results
KW - Primary Health Care/organization & administration
KW - Humans
KW - Middle Aged
KW - Practice Patterns, Physicians'/standards
KW - Quality Indicators, Health Care
KW - Male
KW - Professional Role
KW - Pharmaceutical Services/organization & administration
KW - Patient Care Team/organization & administration
KW - Young Adult
KW - Netherlands
KW - Polypharmacy
KW - Adolescent
KW - Adult
KW - Female
KW - Aged
KW - Outcome Assessment, Health Care
KW - Pharmacists/organization & administration
UR - http://www.scopus.com/inward/record.url?scp=85089389615&partnerID=8YFLogxK
U2 - 10.1007/s11096-020-01075-4
DO - 10.1007/s11096-020-01075-4
M3 - Article
C2 - 32789761
AN - SCOPUS:85089389615
SN - 2210-7703
VL - 42
SP - 1293
EP - 1303
JO - International Journal of Clinical Pharmacy
JF - International Journal of Clinical Pharmacy
IS - 5
ER -